KURA
Kura Oncology Inc
10.70$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.63 | 0.77 | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | -0.01 | -0.01 | -0.01 | 0.63 | 0.77 | |
| – | – | – | – | – | – | 1.97 | 1.79 | 1.09 | 1.14 | 1.33 | 1.14 | 1.14 | 1.28 | 1.39 | 1.57 | 1.97 | 2.86 | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.94 | 0.61 | 0.43 | 0.42 | 0.46 | 0.47 | 0.59 | 0.70 | 0.70 | 0.69 | 0.89 | 1.37 | |
| -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.66 | 2.40 | 1.52 | 1.55 | 1.79 | 1.61 | 1.73 | 1.98 | 2.09 | 2.25 | 2.87 | 4.23 | |
| -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | -2.88 | -2.40 | -1.52 | -1.55 | -1.79 | -1.61 | -1.73 | -1.98 | -2.09 | -2.26 | -2.24 | -3.46 | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.04 | 0.03 | 0.01 | 0.01 | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 | |
| -0.01 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -2.69 | -2.28 | -1.47 | -1.52 | -1.72 | -1.51 | -1.69 | -1.97 | -2.03 | -2.08 | -2.00 | -3.17 | |
| – | – | – | – | – | – | 0.07 | 0.00 | 0.00 | 0.00 | 0.10 | -0.12 | 0.00 | -0.01 | 0.00 | – | 0.02 | 0.00 | |
| -0.01 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -2.69 | -2.28 | -1.47 | -1.52 | -1.72 | -1.51 | -1.69 | -1.97 | -2.03 | -2.08 | -2.02 | -3.18 | |
| -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | -2.88 | -2.40 | -1.52 | -1.55 | -1.79 | -1.61 | -1.67 | -1.95 | -2.01 | -2.05 | -1.97 | -3.15 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.